Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 3, 2007, Pages

  Mohsenin, Amir ^a,b   Mi, Tiejuan ^a   Xia, Yang ^a,b   Kellems, Rodney E ^a,b   Chen, Jiang Fan ^c   Blackburn, Michael R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Asthma; Chemokines; Inflammation

Indexed keywords

ADENOSINE A2 RECEPTOR; CXCL1 CHEMOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; AUTACOID; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; MESSENGER RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL COUNT; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LONGEVITY; LUNG; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; MUCUS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRACHEA; VASCULARIZATION;

ADENOSINE DEAMINASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINES; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; LONGEVITY; LUNG; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUCINS; MUCUS; NEOVASCULARIZATION, PATHOLOGIC; PNEUMONIA; RECEPTOR, ADENOSINE A2A; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER; TRACHEA;

EID: 34548398926     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00187.2007     Document Type: Article

References (50)

1. Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169: 1037-1049, 2002.
2. 2B receptor for 2-(1-Hexynyl) adenosine. Mol Pharmacol 58: 1349-1356, 2000.
3. Blackburn MR. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 24: 66-70, 2003.
4. Blackburn MR, Chun GL, Young HW, Chunn JL, Banerjee SK, Elias JA. Adenosine mediates IL-13-induced inflammation and remodeling in the lung: evidence for an IL-13-adenosine amplification pathway. J Clin Invest 112: 332-344, 2003.
5. Blackburn MR, Datta SK, Kellems RE. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem 273: 5093-5100, 1998.
6. Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, Lee JJ, Kellems RE. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192: 159-170, 2000.
7. Boisvert WA, Rose DM, Johnson KA, Fuentes ME, Lira SA, Curtiss LK, Terkeltaub RA. Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168: 1385-1395, 2006.
8. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMP. Science 184: 19-28, 1974.
9. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19: 9192-9200, 1999.
10. Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167: 4676-4685, 2001.
11. 2 generation, respectively. J Clin Invest 85: 1150-1157, 1990.
12. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158: 1160-1177, 1983.
13. 2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286: G285-G293, 2004.
14. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97, 1993.
15. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 111: 291-297, 2003.
16. 2B receptors. Pharmacol Rev 49: 381-402, 1997.
17. 2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 1979-1986, 1995.
18. 2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 66: 1426-1431, 1996.
19. Fozard JR. The case for a role for adenosine in asthma: almost convincing? Curr Opin Pharmacol 3: 264-269, 2003.
20. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552, 2001.
21. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 294: 1034-1042, 2000.
22. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33-39, 2004.
23. 2a receptor-dependent and independent mechanisms. FASEB J 14: 2065-2074, 2000.
24. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157: 4634-4640, 1996.
25. Henney CS, Lichtenstein LM. The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol 107: 610-612, 1971.
26. 2b adenosine receptor. J Exp Med 204: 117-128, 2007.
27. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar VG, Herjavecz I, Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20: 1393-1398, 2002.
28. Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264, 2006.
29. 2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. Nephron Exp Nephrol 100: e113-e123, 2005.
30. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41: 775-787, 2001.
31. Ma B, Blackburn MR, Lee CG, Homer RJ, Liu W, Flavell RA, Boyden L, Lifton RP, Sun CX, Young HW, Elias JA. Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 116: 1274-1283, 2006.
32. 2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J 20: 187-189, 2006.
33. Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR. Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. FASEB J 21: 1026-1036, 2007.
34. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920, 2001.
35. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol Renal Physiol 277: F404-F412, 1999.
36. Reutershan J, Morris MA, Burcin TL, Smith DF, Chang D, Saprito MS, Ley K. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest 116: 695-702, 2006.
37. Ritchie PK, Spangelo BL, Krzymowski DK, Rossiter TB, Kurth E, Judd AM. Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages. Cytokine 9: 187-198, 1997.
38. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2: 198-204, 1996.
39. 2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172: 7726-7733, 2004.
40. 2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis 189: 1897-1904, 2004.
41. 2A receptor agonists. Br J Pharmacol 132: 1017-1026, 2001.
42. 1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115: 35-43, 2005.
43. 2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 116: 2173-2182, 2006.
44. Teran LM. CCL chemokines and asthma. Immunol Today 21: 235-242, 2000.
45. Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 153: 1099-1112, 1998.
46. Varney ML, Johansson SL, Singh RK. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol 125: 209-216, 2006.
47. 2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116: 1913-1923, 2006.
48. 3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173: 1380-1389, 2004.
49. 2B adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 30: 118-125, 2004.
50. 2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am J Respir Cell Mol Biol 32: 2-8, 2005.